Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Ammitzbøll

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The American Journal of Sports Medicine|June 3, 2020
Clinical Value of Ultrasonographic Assessment in Lateral Epicondylitis Versus Asymptomatic Healthy ControlsThøger P Krogh, Ulrich Fredberg, Christian Ammitzbøll, et al.
Rheumatic Diseases Clinics of North America|November 16, 2024
Considerations for Coronavirus Disease 2019 Vaccination Among B-Cell-Depleted PatientsChristian Ammitzbøll, Marianne Kragh Thomsen, Christian Erikstrup, et al.
The Lancet. Rheumatology|December 26, 2022
National differences in vaccine hesitancy: a concern for the external validity of vaccine studiesChristian Ammitzbøll, Marianne Kragh Thomsen, Christian Erikstrup, et al.
Ugeskrift for Laeger|May 12, 2023
Thomas Weiss, Henrin Bjørnsgaard Madsen, Christian Ammitzbøll, et al.
The Journal of General Physiology|May 1, 2013
TMEM16F (Anoctamin 6), an anion channel of delayed Ca(2+) activationSøren Grubb, Kristian A Poulsen, Christian Ammitzbøll Juul, et al.
Arthritis Care & Research|May 31, 2021
Isolation, Behavioral Changes, and Low Seroprevalence of SARS-CoV-2 Antibodies in Patients With Systemic Lupus Erythematosus or Rheumatoid ArthritisChristian Ammitzbøll, Jakob Bøgh Andersen, Signe Risbøl Vils, et al.
Rheumatology International|January 2, 2021
Similar lipid level changes in early rheumatoid arthritis patients following 1-year treat-to-target strategy with adalimumab plus methotrexate versus placebo plus methotrexate: secondary analyses from the randomised controlled OPERA trialDženan Mašić, Kristian Stengaard-Pedersen, Brian Bridal Løgstrup, et al.
ACR Open Rheumatology|July 17, 2021
Impaired Antibody Response to the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Patients With Systemic Lupus Erythematosus and Rheumatoid ArthritisChristian Ammitzbøll, Lars Erik Bartels, Jakob Bøgh Andersen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 5, 2024
HER2-targeted, enzyme-activated liposomes show superior in vivo efficacy in an ovarian cancer modelChristian Ammitzbøll Juul, Trine Bjørnbo Engel, Frederikke Petrine Fliedner, et al.
Rheumatology International|September 3, 2021
Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritisLars Erik Bartels, Christian Ammitzbøll, Jakob Bøgh Andersen, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The American Journal of Sports Medicine|June 3, 2020
Clinical Value of Ultrasonographic Assessment in Lateral Epicondylitis Versus Asymptomatic Healthy ControlsThøger P Krogh, Ulrich Fredberg, Christian Ammitzbøll, et al.
Rheumatic Diseases Clinics of North America|November 16, 2024
Considerations for Coronavirus Disease 2019 Vaccination Among B-Cell-Depleted PatientsChristian Ammitzbøll, Marianne Kragh Thomsen, Christian Erikstrup, et al.
The Lancet. Rheumatology|December 26, 2022
National differences in vaccine hesitancy: a concern for the external validity of vaccine studiesChristian Ammitzbøll, Marianne Kragh Thomsen, Christian Erikstrup, et al.
Ugeskrift for Laeger|May 12, 2023
Thomas Weiss, Henrin Bjørnsgaard Madsen, Christian Ammitzbøll, et al.
The Journal of General Physiology|May 1, 2013
TMEM16F (Anoctamin 6), an anion channel of delayed Ca(2+) activationSøren Grubb, Kristian A Poulsen, Christian Ammitzbøll Juul, et al.
Arthritis Care & Research|May 31, 2021
Isolation, Behavioral Changes, and Low Seroprevalence of SARS-CoV-2 Antibodies in Patients With Systemic Lupus Erythematosus or Rheumatoid ArthritisChristian Ammitzbøll, Jakob Bøgh Andersen, Signe Risbøl Vils, et al.
Rheumatology International|January 2, 2021
Similar lipid level changes in early rheumatoid arthritis patients following 1-year treat-to-target strategy with adalimumab plus methotrexate versus placebo plus methotrexate: secondary analyses from the randomised controlled OPERA trialDženan Mašić, Kristian Stengaard-Pedersen, Brian Bridal Løgstrup, et al.
ACR Open Rheumatology|July 17, 2021
Impaired Antibody Response to the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Patients With Systemic Lupus Erythematosus and Rheumatoid ArthritisChristian Ammitzbøll, Lars Erik Bartels, Jakob Bøgh Andersen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 5, 2024
HER2-targeted, enzyme-activated liposomes show superior in vivo efficacy in an ovarian cancer modelChristian Ammitzbøll Juul, Trine Bjørnbo Engel, Frederikke Petrine Fliedner, et al.
Rheumatology International|September 3, 2021
Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritisLars Erik Bartels, Christian Ammitzbøll, Jakob Bøgh Andersen, et al.
Pageof 2